Purple Biotech (PPBT) Competitors $3.42 -0.03 (-0.87%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends PPBT vs. IBIO, PULM, NNVC, BFRG, COCP, TENX, CTXR, CGTX, FNCH, and CVKDShould you be buying Purple Biotech stock or one of its competitors? The main competitors of Purple Biotech include iBio (IBIO), Pulmatrix (PULM), NanoViricides (NNVC), Bullfrog AI (BFRG), Cocrystal Pharma (COCP), Tenax Therapeutics (TENX), Citius Pharmaceuticals (CTXR), Cognition Therapeutics (CGTX), Finch Therapeutics Group (FNCH), and Cadrenal Therapeutics (CVKD). These companies are all part of the "pharmaceutical products" industry. Purple Biotech vs. iBio Pulmatrix NanoViricides Bullfrog AI Cocrystal Pharma Tenax Therapeutics Citius Pharmaceuticals Cognition Therapeutics Finch Therapeutics Group Cadrenal Therapeutics iBio (NYSE:IBIO) and Purple Biotech (NASDAQ:PPBT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, community ranking, risk, media sentiment, analyst recommendations, earnings, valuation, dividends and institutional ownership. Is IBIO or PPBT more profitable? Purple Biotech's return on equity of -55.86% beat iBio's return on equity.Company Net Margins Return on Equity Return on Assets iBioN/A -78.53% -41.79% Purple Biotech N/A -55.86%-44.67% Which has more volatility & risk, IBIO or PPBT? iBio has a beta of -3.24, meaning that its stock price is 424% less volatile than the S&P 500. Comparatively, Purple Biotech has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Do institutionals and insiders hold more shares of IBIO or PPBT? 7.9% of iBio shares are owned by institutional investors. Comparatively, 9.6% of Purple Biotech shares are owned by institutional investors. 0.6% of iBio shares are owned by insiders. Comparatively, 3.0% of Purple Biotech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community favor IBIO or PPBT? Purple Biotech received 14 more outperform votes than iBio when rated by MarketBeat users. Likewise, 94.44% of users gave Purple Biotech an outperform vote while only 42.86% of users gave iBio an outperform vote. CompanyUnderperformOutperformiBioOutperform Votes342.86% Underperform Votes457.14% Purple BiotechOutperform Votes1794.44% Underperform Votes15.56% Do analysts recommend IBIO or PPBT? iBio presently has a consensus price target of $4.30, suggesting a potential upside of 73.39%. Purple Biotech has a consensus price target of $33.00, suggesting a potential upside of 864.91%. Given Purple Biotech's higher possible upside, analysts plainly believe Purple Biotech is more favorable than iBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iBio 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Purple Biotech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings and valuation, IBIO or PPBT? Purple Biotech has lower revenue, but higher earnings than iBio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiBio$175K129.65-$24.91MN/AN/APurple BiotechN/AN/A-$19.88M-$8.79-0.39 Does the media refer more to IBIO or PPBT? In the previous week, iBio had 2 more articles in the media than Purple Biotech. MarketBeat recorded 2 mentions for iBio and 0 mentions for Purple Biotech. iBio's average media sentiment score of 0.00 equaled Purple Biotech'saverage media sentiment score. Company Overall Sentiment iBio Neutral Purple Biotech Neutral SummaryPurple Biotech beats iBio on 8 of the 12 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get Purple Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PPBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PPBT vs. The Competition Export to ExcelMetricPurple BiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.55M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E Ratio-0.3910.5589.7417.16Price / SalesN/A196.061,117.09117.04Price / CashN/A57.1643.1037.86Price / Book0.135.094.784.78Net Income-$19.88M$151.83M$120.31M$225.60M7 Day Performance-10.70%-2.14%-1.92%-1.23%1 Month Performance56.16%-4.56%13.65%0.46%1 Year PerformanceN/A8.87%28.34%15.24% Purple Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PPBTPurple Biotech1.6713 of 5 stars$3.42-0.9%$33.00+864.9%N/A$4.55MN/A-0.3920IBIOiBio0.988 of 5 stars$2.32+0.4%$4.30+85.3%N/A$21.23M$175,000.000.00100PULMPulmatrix0.1923 of 5 stars$5.78+0.5%N/A+198.5%$21.10M$7.30M-2.1820Analyst ForecastNews CoverageNNVCNanoViricidesN/A$1.50+1.0%N/A+40.6%$20.86MN/A-1.9520BFRGBullfrog AI0.7327 of 5 stars$2.35+5.9%N/A-24.8%$20.48M$60,000.00-2.744News CoverageCOCPCocrystal Pharma2.6583 of 5 stars$2.00+4.8%$7.00+250.0%+19.0%$20.35MN/A-1.0310TENXTenax Therapeutics1.4593 of 5 stars$5.85-0.5%$16.00+173.5%-76.7%$19.95MN/A0.009News CoverageCTXRCitius Pharmaceuticals1.6605 of 5 stars$2.74-1.8%$100.00+3,549.6%-86.2%$19.81MN/A-0.4720Gap DownCGTXCognition Therapeutics2.8994 of 5 stars$0.46-2.8%$8.00+1,622.7%-62.9%$19.30MN/A-0.4920Analyst ForecastNews CoverageFNCHFinch Therapeutics GroupN/A$11.75-2.1%N/A+251.4%$18.87M$110,000.00-1.36190News CoverageCVKDCadrenal Therapeutics1.7091 of 5 stars$11.29+0.8%$18.00+59.4%N/A$18.73MN/A-1.684News CoverageGap Up Related Companies and Tools Related Companies iBio Competitors Pulmatrix Competitors NanoViricides Competitors Bullfrog AI Competitors Cocrystal Pharma Competitors Tenax Therapeutics Competitors Citius Pharmaceuticals Competitors Cognition Therapeutics Competitors Finch Therapeutics Group Competitors Cadrenal Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PPBT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
